Omicron News and Research

RSS

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

In a new study, risk assessments for research, survey, monitoring, management, wildlife rehabilitation, and wildlife control were updated regarding SARS-CoV-2.

21 Apr 2022

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Researchers surveyed over 360 COVID-19 patients to characterize the SARS-CoV-2 genomic sequence diversity of individual infections.

21 Apr 2022

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

Researchers developed an immunoantiviral, NanoSTING, and demonstrated its broad-spectrum antiviral properties in hamsters and mice.

21 Apr 2022

CDC announces two COVID-19 travel-related updates based on current scenario

Today, CDC is announcing two COVID-19 travel-related updates based on close-monitoring of the COVID-19 landscape in the United States and internationally.

20 Apr 2022

Natural immunity provides a longer window of protection against COVID-19 infection than mRNA vaccines

A study released in JAMA Network Open by investigators at Providence, one of the largest health systems in the United States, and the University of Chicago, found that the level of protection granted by a prior symptomatic COVID-19 infection among unvaccinated individuals was on par with the level of protection provided by mRNA vaccines, with natural immunity providing a longer window of protection than mRNA vaccines.

20 Apr 2022

Study: 43% of the people infected with COVID-19 experienced post-COVID conditions

Around the world, 43 percent of those infected with COVID-19 experienced post-COVID conditions, according to a new analysis by University of Michigan School of Public Health that looked at data from 50 studies and 1.6 million people.

20 Apr 2022

Investigating the impact of SARS-CoV-2 Omicron spike mutations

Researchers investigated the impact of amino acid substitutions of SARS-CoV-2 Omicron on spike protein function, processing, and neutralization susceptibility.

20 Apr 2022

Study investigates co-metabolism during SARS-CoV-2 infection

In a new study, researchers investigated host-virus co-metabolism during a SARS-CoV-2 infection.

20 Apr 2022

Exploring the vaccine effectiveness of COVID-19 booster vaccine doses

In a new study, researchers compared the effectiveness of the COVID-19 booster vaccine to that of the primary vaccine series.

20 Apr 2022

The impact of COVID-19 vaccine hesitancy and resistance on the population of England

A study conducted by the UK Health Security Agency has recently estimated the rate of hospitalization and death due to COVID-19 among unvaccinated persons residing in England.

20 Apr 2022

Waning antibody responses in SARS-CoV-2-infected children and adults over time

In a new study, researchers evaluated the duration of antibodies against SARS-CoV-2.

20 Apr 2022

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

In a new study, researchers assessed the impact of the SARS-CoV-2 Omicron variant on infected human cells and organs.

20 Apr 2022

Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

Researchers characterized vaccine-induced T cell response specific for spike proteins of several SARS-CoV-2 variants.

20 Apr 2022

The epidemiological features of SARS-CoV-2 infections in the fifth wave in Hong Kong

A recent report presented the epidemiology of the SARS-CoV-2 Omicron BA.2 sublineage infections in Hong Kong.

20 Apr 2022

New point-of-care COVID-19 test can differentiate alpha variant from earlier SARS-CoV-2 strains

A point-of-care COVID-19 test developed by researchers at the University of Illinois Urbana-Champaign can now detect and differentiate the alpha variant of the SARS-CoV-2 virus from earlier strains in saliva samples.

20 Apr 2022

Fully vaccinated HIV patients may be less susceptible to develop severe breakthrough SARS-CoV-2 infection

A new study found that the risk of severe breakthrough infection of SARS-CoV-2 is low among fully vaccinated HIV patients.

19 Apr 2022

Better ventilation can prevent covid spread. But are companies paying attention?

Americans are abandoning their masks. They're done with physical distancing. And, let's face it, some people are just never going to get vaccinated.

19 Apr 2022

COVID-19 vaccine reduced the risk of hospitalizations in children during the Omicron period

Results of a new multicenter study published in the New England Journal of Medicine found that vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine reduced the risk of COVID-19-associated hospitalizations in children ages 5–11 years by two-thirds during the Omicron period.

19 Apr 2022

New, longest documented case of persistent acute SARS-CoV-2 infection

Researchers describe a 16-month-old case of SARS-CoV-2 infection in an immunocompromised individual.

18 Apr 2022

New research on immune correlates for Janssen Ad26.Cov2.S COVID vaccine

ENSEMBLE data was used to evaluate three immune markers as correlates of protection following a single dose of Ad26.COV2.S vaccine.

18 Apr 2022

Omicron News and Research

Researchers conduct SARS-CoV-2 risk assessment with regard to wildlife research, rehabilitation, and control

Study evaluates SARS-CoV-2 whole genome data from patients and staff in the VA Northeast Ohio Healthcare System

Intranasal nanoparticle STING agonist with immunoantiviral activity against SARS-CoV-2 variants

CDC announces two COVID-19 travel-related updates based on current scenario

Natural immunity provides a longer window of protection against COVID-19 infection than mRNA vaccines

Study: 43% of the people infected with COVID-19 experienced post-COVID conditions

Investigating the impact of SARS-CoV-2 Omicron spike mutations

Study investigates co-metabolism during SARS-CoV-2 infection

Exploring the vaccine effectiveness of COVID-19 booster vaccine doses

The impact of COVID-19 vaccine hesitancy and resistance on the population of England

Waning antibody responses in SARS-CoV-2-infected children and adults over time

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

The epidemiological features of SARS-CoV-2 infections in the fifth wave in Hong Kong

New point-of-care COVID-19 test can differentiate alpha variant from earlier SARS-CoV-2 strains

Fully vaccinated HIV patients may be less susceptible to develop severe breakthrough SARS-CoV-2 infection

Better ventilation can prevent covid spread. But are companies paying attention?

COVID-19 vaccine reduced the risk of hospitalizations in children during the Omicron period

New, longest documented case of persistent acute SARS-CoV-2 infection

New research on immune correlates for Janssen Ad26.Cov2.S COVID vaccine

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News